Anne Sissel is the Vice President and Head of Baxter Ventures. Baxter Ventures is the corporate venture capital fund of Baxter International, investing in companies with innovative technologies, products and/or therapies.
Prior to Baxter, Anne was on the executive team for Veracyte, Inc. leading the finance and business development organization from early discovery through commercialization. Prior to Veracyte, Anne worked in the Investment Banking Division of Goldman, Sachs & Co. in New York and San Francisco. Anne has completed over $200bn in financing and M&A transactions for clients in the healthcare industry.
Anne holds an MBA from the Wharton School of the University of Pennsylvania and a BS in Finance from Indiana University. She was selected to Crain’s Chicago Business Top 40 Under 40 in 2016. Anne’s current Board and Observation roles representing Baxter include: Kit Check, Medasense, TVA Medical and VitalConnect.